Navigation Links
OncoGenex Reports Third Quarter Financial Results
Date:11/10/2008

cently filed Quarterly Report on Form 10-Q. No assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of the Company. The Company undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof.

Condensed Statements of Operations

(Unaudited)

(in thousands)

Three Months Nine Months

Ended Ended

September 30, September 30,

2008 2007 2008 2007

Operating expenses

Research and development $ 1,639 $ 1,094 $ 3,621 $ 3,075

General and administrative 1,024 609 2,243 2,709

------------------- -------------------

Total operating expenses 2,663 1,703 5,864 5,784

------------------- -------------------

Other income (expense) 297 (27) 88 44

------------------- -------------------

Loss for the period before taxes (2,366) (1,730) (5,776) (5,740)

Income tax expense (recovery) (2,515) 200 (2,100) 573

------------------- -------------------

Operating income (loss) before

extraordinary gain 149 (1,930) (3,676) (6,313)

Extraordinary gain 4,428 - 4,428 -

-------------------
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
2. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
3. OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
4. OncoGenex increases economic interest in lead cancer drug OGX-011
5. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. FDA Grants Fast Track Designation for OncoGenex Pharmaceuticals Lead Product Candidate OGX-011
8. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
9. OncoGenex To Present At The BioContact Quebec 2008 Annual Conference
10. OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
11. OncoGenex Pharmaceuticals to Release Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 26, 2015 PRC Clinical, a Silicon-Valley ... several management and executive appointments effective immediately. , Mike ... (CFO) and member of the Board of Directors. Daniel ... and Sue Dowden will assume the position of Senior ... Chief Operations Officer (COO), has been appointed to the ...
(Date:3/26/2015)... and CINCINNATI , ... plc (LSE: SHP, NASDAQ: SHPG ) and ... three-year, broad research collaboration for rare diseases. The goal ... novel therapies to treat rare diseases with high ... capabilities with Cincinnati Children,s research expertise. As a ...
(Date:3/26/2015)... America," the popular news television program that airs in numerous ... film actor James Earl Jones, has announced that it will ... , Botany is commonly described as the scientific study of ... more complicated than that. Scientists and other professionals study a ... smallest bacteria known to man to the largest trees that ...
(Date:3/25/2015)... (PRWEB) March 26, 2015 Agnition announced ... episode of American Farmer, airing for the first time ... segment of American Farmer will explore the extremely important ... crop producers with a patented Microbial Catalystâ„¢ technology that ... greater yields. The segment will air again on April ...
Breaking Biology Technology:PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2
... Calif., Oct. 22 Maven Biotechnologies, LLC,an ... multiplexing,immunodiagnostic analysis system, today announced that the ... Investor Conference in San Diego,California. Jeffrey C. ... on Thursday, November 1, 2007 at 3:30 ...
... and Advice Shared Through Dynamic WikiAnswers Q&A ... ... In a show of support for National,Breast Cancer Awareness Month, Answers.com,s ... http://wiki.answers.com/Q/FAQ/2375 ), where breast cancer survivors,friends and family have gathered to ...
... Facility Win Needed Medical ... Pa., Oct. 22 Television medical dramas such as,ER and ... the country to millions of Americans each week. Now, small ... system - are being given the opportunity to turn the ...
Cached Biology Technology:Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference 2Answers.com's WikiAnswers Supervisors Rallying for National Breast Cancer Awareness Month 2Answers.com's WikiAnswers Supervisors Rallying for National Breast Cancer Awareness Month 3American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 2American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest 3
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ... Biometrics - Global Strategic Business Report" report to their offering. ... Voice Biometrics in US$ Thousands by the following Segments: Face Biometrics, ... US, Canada , Japan , ... Middle East & Africa , ...
(Date:3/23/2015)... March 23, 2015  In the 2014 fiscal year, ... conviction losses. This figure accounts for a fraction of ... The Nilson Report, exceeds $11 billion globally. The polygraph ... a crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test ...
(Date:3/20/2015)... Mar. 19, 2015 Research and Markets ( ... Biometrics - Global Strategic Business Report" report to their ... Iris Biometrics in US$ Thousands. The report provides separate comprehensive ... Japan , Europe , ... and Latin America . Annual ...
Breaking Biology News(10 mins):Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... Support Services Unrestricted (BOSS-U) ProgramSAN DIEGO and MCLEAN, ... (NYSE: SAI ) today announced it ... Biometrics Task Force (BTF) to provide biometrics support ... Support Services Unrestricted (BOSS-U) program. The multiple award, ...
... New research supports a modest beneficial effect of anakinra ... for serious infections and its use with other biologic ... affecting as many as one in 100 people worldwide. ... Anakinra is one of a new breed of arthritis ...
... surgeons who add virtual reality (VR) training to standard ... with greater accuracy and have less errors than those ... those who use additional video training. The finding of ... is time-consuming and costly, and surgeons have to develop ...
Cached Biology News:U.S. Army Biometrics Task Force Awards Contract to SAIC 2Anakinra for rheumatoid arthritis: A modest benefit with some risk 2Virtual reality: Keyhole surgeons training could help meet European working time directives 2
... Thermomixer R offers maximum application versatility ... heating, and cooling. Its active heating/cooling ... and temperature control ranges. Five different ... micro test tubes, are available for: ...
Rabbit polyclonal antibody to GluR2...
Mouse monoclonal antibody raised against a partial recombinant TPR. NCBI Entrez Gene ID = TPR...
... Array II can be used to test ... proteins and sera that are commonly used ... array contains spots for 19 different protein ... of antibody crossreactivity and species specificity, QC ...
Biology Products: